Business
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recogni...
About this update from Go Metals Corp.
[{"type":"text","content":"Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm\n\n\n\n NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO), Semler Scientific Inc. (NASDAQ:SMLR), Fulgent Genetics, Inc. (NASDAQ: FLGT), and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.\n \n\n\n Semler Scientific Inc. (NASDAQ:SMLR)\n \n\n\n On February 28, 2025, Semler filed its Form 10-K with the SEC and therein, disclosed that the Company received an initial civil investigative demand from the U.S. Department of Justice (\"DOJ\") in July 2017 regarding Semler's claims for reimbursement related to its QuantaFlo device. Semler received subsequent requests for information in February 2019, December 2021, April 2022, and April 2023. In February 2025, Semler participated in settlement discussions with the DOJ, which were unsuccessful. The Company disclosed that \"there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.\" On this news, the price of Semler shares declined by $4.03 per share, from $42.92 per share on February 28, 2025, to close at $38.89 on March 3, 2025.\n \n\n For more information on the Semler investigation go to:\n \n https://bespc.com/cases/SMLR\n \n\n\n\n GoHealth, Inc. (NASDAQ:GOCO)\n \n\n\n On May 1, 2025, the U.S. Department of Justice (\"DOJ\") announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including GoHealth, \"alleging that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers' Medicare Advantage plans.\"\n \n\n On news of the DOJ's lawsuit, GoHealth's stock price fell $1.09 per share, or 10.35%, to close at $9.44 per share on May 1, 2025.\n \n\n For more information on the GoHealth investigation go to:\n \n https://bespc.com/cases/G...